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Depletion of Mitochondrial DNA Stabilizes C1qTNF-Related 
Protein 6 mRNA in Muscle Cells
Mutation and reduction of mitochondrial DNA (mtDNA) have been suggested as factors in 
the pathogenesis of several metabolic diseases. Recently, we demonstrated that C1qTNF-
related protein-6 (CTRP6) is involved in fatty acid metabolism in muscle cells. In this study, 
we showed that expression of CTRP6 was up-regulated in mtDNA-depleted C2C12 cells, 
which displayed a marked decrease in cellular mtDNA and ATP content. Replacement of 
mtDNA normalized the expression level of CTRP6 similar to that in normal C2C12 cells, 
indicating that CTRP6 expression was up-regulated by mtDNA depletion. However, CTRP6 
promoter activity remained unchanged in mtDNA-depleted cells. We also found that 
mtDNA depletion inhibited decay of CTRP6 mRNA. Taken together, mtDNA depletion 
induces an increase in CTRP6 expression by increasing mRNA stability.
Key Words: DNA, Mitochondrial; CTRP6; C1qTNF-6; mRNA Stability; C2C12 Cells 
Mi-Jin Kim*, Wan Lee*, Eun-Ju Park,  
and Seung-Yoon Park
Department of Biochemistry, Dongguk University 
School of Medicine, Gyeongju, Korea
*Mi-Jin Kim and Wan Lee contributed equally to 
this work.
Received: 3 October 2011
Accepted: 26 January 2012
Address for Correspondence:
Seung-Yoon Park, MD
Department of Biochemistry, Dongguk University School of 
Medicine, 87 Dongdae-ro, Gyeongju 780-714, Korea
Tel: +82.54-770-2421, Fax: +82.54-770-2447
E-mail: psyoon@dongguk.ac.kr
This study was supported by the Basic Science Research Program 
through the National Research Foundation of Korea (NRF) funded 
by the Ministry of Education, Science and Technology (2011-
0016102) and by a grant from 21C Frontier Functional Proteomics 
Project from Ministry of Education, Science and Technology 
(M108KM010008-08K1301-00810).
http://dx.doi.org/10.3346/jkms.2012.27.5.465  •  J Korean Med Sci 2012; 27: 465-470
ORIGINAL ARTICLE
Basic Medical Sciences 
INTRODUCTION
C1qTNF-related protein 6 (CTRP6) was initially identified as a 
member of adiponectin paralogs (1). It consists of an N-termi-
nal signal peptide, a collagen repeat, and a C-terminal globular 
domain, and it is widely expressed in many tissues. We previ-
ously demonstrated that CTRP6 is involved in fatty acid metab-
olism in muscle cells by activating AMP-activated protein kinase 
(AMPK) (2). Recently, we showed that CTRP6 and its globular 
domain induce IL-10 expression in macrophages (3). However, 
the regulatory mechanism of CTRP6 expression remains largely 
unknown. 
  Mitochondrial dysfunction has been implicated in several 
metabolic diseases, such as obesity, hyperlipidemia, and diabe-
tes (4). We previously showed that depletion of mtDNA in mus-
cle cells decreases the expression of insulin receptor substrate-1 
(IRS-1), thereby causing impaired glucose utilization and insu-
lin resistance (5). Mitochondria-to-nucleus stress signaling re-
sults in a variety of changes in nuclear gene expression (6-8). A 
recent study observed that CTRP6 expression is increased in 
adipose tissue of 8-week-old and 12-week-old ob/ob mice (1). 
The activity of mitochondrial respiratory chain complexes in 
ob/ob mice is between 30% to 50% lower compared to that in 
wild-type animals (9). Our recent study showed that mtDNA 
depletion increases the expression of C1qTNF-related protein 5 
(CTRP5) gene (10), which shares structural and functional prop-
erties with CTRP6. Thus, we investigated the change in CTRP6 
expression in response to mtDNA depletion. In this study, we 
provide evidence that depletion of mtDNA up-regulated CTRP6 
expression via an increase in mRNA stability. 
MATERIALS AND METHODS
Reagents and antibodies 
Polyclonal anti-CTRP6 antibody was purchased from Abcam 
(Cambridge, MA, USA). Polyclonal anti-actin antibody was ob-
tained from Sigma (St. Louis, MO, USA). Horseradish peroxidase 
(HRP)-conjugated anti-mouse IgG and anti-rabbit IgG were ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Oligonucleotide primers were purchased from Bionics (Seoul, 
Korea). Sodium pyruvate, uridine, and actinomycin D were ob-
tained from Sigma.
Cell culture
C2C12 cells were maintained in DMEM (high glucose) medium 
supplemented with 10% (v/v) fetal bovine serum (FBS, Invitro-Kim M-J, et al.  •  Effect on mtDNA Depletion in CTRP6 Expression 
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gen, Carlsbad, CA, USA) and appropriate antibiotics. Depletion 
of mtDNA was induced by treatment with ethidium bromide 
(EtBr, 0.2 μg/mL) for 2-3 weeks. EtBr-treated C2C12 cells were 
grown in the presence of 1 mM sodium pyruvate and 50 μg/mL 
uridine, which have been shown to be essential for the growth of 
cells lacking mtDNA (11). Control C2C12 cells were maintained 
for the same time period under normal culture conditions. Re-
moval of EtBr from the medium restored the mtDNA content to 
a level similar to that of control C2C12 cells within 4 weeks.
Genomic DNA extraction and polymerase chain reaction 
(PCR)
Total genomic DNA was isolated from control, mtDNA-depleted, 
and reverted C2C12 cells using a DNeasy Tissue kit in accor-
dance with the manufacturer’s instructions (Qiagen, Valencia, 
CA, USA). The amplification of mtDNA was performed under 
the following conditions: 94°C for 2 min (initial denaturation); 
94°C for 30 sec, 55°C for 30 sec, 72°C for 30 sec (25 cycles for COX-
III and GAPDH; 30 cycles for COX-I and COX-IV); and 72°C for 
10 min (final extension). The primers used in this study are shown 
in Table 1.
RNA extraction, RT-PCR, and quantitative real-time PCR
Total RNA was extracted from control, mtDNA-depleted, and 
reverted C2C12 cells using Trizol reagent in accordance with the 
manufacturer’s instructions (Invitrogen). The reverse transcrip-
tion reaction was performed using M-MLV reverse transcriptase 
according to the manufacturer’s instructions (Promega, Madi-
son, WI, USA). The amplification of CTRP6 was performed un-
der the following conditions: 94°C for 2 min (initial denatur-
ation); 94°C for 30 sec, 55°C for 30 sec, 72°C for 45 sec (30 cycles 
for CTRP6; 25 cycles for β-actin); and 72°C for 10 min (final ex-
tension). The primers used in this study are shown in Table 1. 
For real-time PCR, the resulting cDNA was diluted 2.5-fold and 
used to amplify CTRP6 or β-actin as a control. Real-time PCR am-
plification was carried out using SYBR green master mix (Roche 
Applied Science) in a LightCycler 480 (Roche Applied Science, 
Mannheim, Germany) as follows: initial denaturation at 95°C 
for 5 min; 45 cycles of amplification with denaturation at 95°C 
for 30 sec, annealing at 58°C for 30 sec, and extension at 72°C for 
30 sec; 1 cycle of melting curves at 95°C for 5 sec, 65°C for 1 min, 
and 97°C continuous; and a final cooling step at 40°C for 30 sec. 
The comparative cycle threshold (CT) method was used to ana-
lyze the data by generating relative values of the amount of tar-
get cDNA as previously described (5). 
Measurement of cellular ATP levels
Cellular ATP levels were measured using a Somatic cell ATP as-
say kit (Sigma, St. Louis, MO, USA) as previously described (12). 
Briefly, cells were lysed with an ATP releasing solution (Sigma), 
and the lysates were assayed for luciferase activity in accordance 
with the manufacturer’s instructions (Sigma). ATP-dependent 
formation of light was measured in a Luminometer (Berthold 
Technologies, Bad Wildbad, Germany) with appropriate ATP 
standards.
Western blotting
Equal amounts (20 μg) of total cell lysates were subjected to SDS-
PAGE on 10% resolving gels as previously described (13). Sepa-
rated proteins were electrophoretically transferred to a nitrocel-
lulose membrane (Bio-Rad, Philadelphia, PA, USA). The mem-
brane was blocked with 5% skim milk in Tris-buffered saline 
(TBS), followed by incubation with anti-CTRP6 or anti-actin 
antibody overnight at 4°C. After washing with TTBS (TBS with 
0.1% Tween 20), the membrane was incubated with HRP-con-
jugated anti-mouse or anti-rabbit IgG for 1 hr at room tempera-
ture. Blots were developed using an enhanced chemilumines-
cence (ECL) kit (Amersham, Buckinghamshire, UK).
Dual luciferase reporter assay 
The mouse CTRP6 promoter region (pCTRP6-1064/+126) was 
amplified from genomic DNA of C2C12 cells by PCR using the 
following primers: forward primer, 5´-AAA AGC TAC CCT CGT 
TCC ACC CCT AGT C-3´; reverse primer, 5´-AAA ACT CGA GCC 
TGC GGC CTC AAC GTG AAC-3´. The PCR product was cloned 
into the NheI-XhoI sites of the pGL3/basic vector (Promega, 
Madison, WI, USA). Control, mtDNA-depleted, and reverted 
C2C12 cells in a 6-well plate were cotransfected with pCTRP6-
luc vector together with pRL-SV40 for constitutive expression of 
Renilla luciferase as an internal control. Luciferase activity was 
measured 48 hr after transfection using a Dual Luciferase assay 
kit (Promega, Madison, WI, USA). The ratio of firefly luciferase 
activity to Renilla luciferase activity was presented as fold induc-
tion of that observed in control C2C12 cells.
mRNA stability analysis
Control, mtDNA-depleted, and reverted C2C12 cells were incu-
Table 1. Primers used for genomic DNA PCR and quantitative real-time PCR
Identity Nucleotide sequences
Product size
gDNA mRNA
COX-I Forward: 5´-TAGTAGAAGCAGGAGCAGGAAC-3´
Reverse: 5´-TTAGGTTGCGGTCTGTTAGTAG-3´
297 297
COX-III Forward: 5´-GACCCACCAAACTCATGCAT-3´
Reverse: 5´-ATGTAATTGAAACACCTGATGC-3´
434 434
COX-IV Forward: 5´-GGAGTGTTGTGAAGAGTGAAG-3´
Reverse: 5´-GCAGTGAAGCCAATGAAGAAC-3´
597 271
CTRP6 Forward: 5´-CAGTATTCCTGCTTCCTCTTG-3´
Reverse: 5´-TACCATTCTTGCCTGGCTTC-3´
N/A 261
GAPDH Forward: 5´-TGCCACCCAGAAGACTGTG-3´
Reverse: 5´-ATGTAGGCCATGAGGTCCAC-3´
446 446
β-actin Forward: 5´-TCACCCACACTGTGCCCATCTACGA-3´
Reverse: 5´-GGATGCCACAGGATTCCATACCCA-3´
N/A 348
gDNA, genomic DNA; N/A, not applicable.Kim M-J, et al.  •  Effect on mtDNA Depletion in CTRP6 Expression 
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bated with 12.5 μg/mL actinomycin D to inhibit transcription. 
The cells were harvested at six different time points following 
actinomycin addition, after which total RNA was isolated as de-
scribed above. The level of CTRP6 transcript was analyzed by 
RT-PCR and quantitative real-time PCR.
Statistical analysis 
The statistical significance was assessed by the t-test. A P < 0.05 
was considered to be statistically significant.
RESULTS 
Establishment and characterization of mtDNA-depleted 
C2C12 cells
To generate partially mtDNA-depleted muscle cell lines, we 
treated C2C12 cells with EtBr in medium containing pyruvate 
and uridine, which are known to be essential for the growth of 
mtDNA-depleted cells (11). The mtDNA content of the EtBr-
treated C2C12 cells was measured by amplifying genomic DNA. 
As shown in Fig. 1A, cytochrome oxidase subunits I (COX-I) and 
III (COX-III), which are encoded only in mtDNA, were rarely am-
plified from the genomic DNA of the EtBr-treated C2C12 cells 
compared to the control C2C12 cells. Removal of EtBr from the 
culture medium (reverted cells) restored the mtDNA content   
of the mtDNA-depleted cells to a level similar to that of control 
C2C12 cells (Fig. 1A). In contrast, nuclear DNA-encoded COX-
IV was equally detected in control, mtDNA-depleted, and re-
verted cells (Fig. 1A). We next analyzed the differential expres-
sion of COX-I, -III, and -IV genes in the control, mtDNA-deplet-
ed, and reverted cells using quantitative real-time PCR. As shown 
in Fig. 1B, the mRNA contents of COX-I and COX-III were sig-
nificantly reduced in the mtDNA-depleted cells, whereas the 
mRNA content of COX-IV remained unchanged, indicating that 
mitochondrial mRNA levels correlated with cellular mtDNA con-
tents in C2C12 cells. In addition, the mtDNA-depleted C2C12 
cells showed a substantial decrease in total cellular ATP com-
Fig. 1. Establishment and characterization of mtDNA-depleted C2C12 cells. (A) Genomic DNA content. Genomic DNA was isolated from control, mtDNA-depleted, and reverted 
C2C12 cells, and mtDNA-encoded genes, including cytochrome c oxidase subunit I (COX-I) and cytochrome c oxidase subunit III (COX-III), were amplified by PCR. COX-IV was 
used as a nuclear DNA-encoded control. A representative result of at least three independent experiments is shown. (B) Contents of mRNAs transcribed from mtDNA and nuclear 
DNA. Total RNA was extracted from control, mtDNA-depleted, and reverted C2C12 cells, and levels of COX-I, COX-III, and COX-IV transcripts were analyzed by quantitative real-
time PCR. The mRNA levels were expressed as a percentage of that observed in control C2C12 cells, which were set as 100%. Results are expressed as the means ± SD of 
three independent experiments. t-test: *P < 0.01 vs control C2C12 cells. (C) Cellular ATP content. Total cellular ATP levels were analyzed using a somatic cell ATP assay kit 
(Sigma). ATP content was expressed as a percentage of that observed in control C2C12 cells. Results are expressed as the means ± SD of three independent experiments.         
t-test: *P < 0.01 vs control C2C12 cells.
Fig. 2. Expression of CTRP6 mRNA and protein in control, mtDNA-depleted, and re-
verted C2C12 cells. (A) Total RNA was isolated from control, mtDNA-depleted, and 
reverted C2C12 cells, and the level of CTRP6 mRNA was analyzed by quantitative re-
al-time PCR. The relative values are expressed as a fold increase of that observed in 
control C2C12 cells. Results are expressed as the means ± SD of three independent 
experiments. t-test: *P < 0.01 vs control C2C12 cells. (B) Cell lysates were prepared 
from control, mtDNA-depleted, and reverted C2C12 cells. Equal amounts (20 µg pro-
teins) of cell lysates were separated via 10% SDS-PAGE and subjected to immunob-
lotting with anti-CTRP6 or anti-actin antibody. A representative result of three inde-
pendent experiments is shown. 
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pared to control and reverted C2C12 cells (Fig. 1C).
CTRP6 in mtDNA-depleted C2C12 cells
It was previously reported that CTRP5 is increased in mtDNA-
depleted myocytes and activates AMP-activated protein kinase 
(AMPK) (10). Recently, we found that CTRP6 is also involved in 
fatty acid metabolism via AMPK activation (2). To investigate 
the change in CTRP6 expression in response to mtDNA deple-
tion, we measured the expression levels of CTRP6 mRNA in con-
trol, mtDNA-depleted, and reverted C2C12 cells using quantita-
tive real-time PCR. Expression of CTRP6 mRNA was up-regu-
lated in mtDNA-depleted cells by 2.5-fold compared with con-
trol C2C12 cells (Fig. 2A). In agreement with the results of the 
mRNA analysis, the protein expression level of CTRP6 also sig-
nificantly increased in mtDNA-depleted C2C12 cells compared 
to control C2C12 cells (Fig. 2B). Replacement of mtDNA restored 
both mRNA and protein expression of CTRP6 to levels resembling 
those in control C2C12 cells (Fig. 2). These results indicate that 
mtDNA depletion induced up-regulation of CTRP6 expression. 
CTRP6 expression and mRNA stability
To determine whether or not the increase in CTRP6 mRNA level 
was due to transcriptional activation, we generated a mouse 
CTRP6 promoter fragment upstream of the luciferase reporter 
gene. However, the activity of the mouse CTRP6 promoter was 
the same among control, mtDNA-depleted, and reverted C2C12 
cells (Fig. 3). Since the increase in steady-state CTRP6 mRNA 
level was evidently not due to transcriptional activation, we in-
vestigated whether or not the rate of mRNA decay might change 
under mtDNA-depleted conditions. To analyze CTRP6 mRNA 
decay in control, mtDNA-depleted, and reverted C2C12 cells, we 
treated cells with actinomycin D, a transcription inhibitor, and 
examined CTRP6 mRNA levels for the indicated times. As shown 
in Fig. 4A, decay of CTRP6 mRNA was inhibited in mtDNA-de-
leted cells compared with control and reverted C2C12 cells. In 
contrast, the mRNA level of a long-lived message (beta-actin) 
was unchanged in control, mtDNA-depleted, and reverted cells. 
The half-life of CTRP6 mRNA increased from approximately 2 hr 
in normal C2C12 cells to longer than 8 hr in the mtDNA-deplet-
ed C2C12 cells (Fig. 4B). Furthermore, replacement of mtDNA 
restored CTRP6 mRNA decay to a level similar to that in control 
C2C12 cells. Thus, up-regulation of CTRP6 mRNA by mtDNA 
depletion was due to an increase in mRNA stability.
DISCUSSION
Long-term treatment with low dose EtBr specifically inhibits rep-
lication and transcription of mtDNA without affecting nuclear 
DNA replication and transcription (14-16), and it has been a use-
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ful tool for the investigation of various cellular changes in re-
sponse to mtDNA depletion (12, 17, 18). Mitochondrial dysfunc-
tion induces mitochondria-to-nucleus stress signaling, which 
changes the expression levels of various nuclear-encoded genes 
(17-19). In the present study, we generated C2C12 cells contain-
ing partially depleted mtDNA (less than 80% of control cells) due 
to EtBr treatment and showed that depletion of mtDNA led to the 
increased expression of both CTRP6 mRNA and protein. How-
ever, the activity of mouse CTRP6 promoter was not increased 
in mtDNA-depleted cells compared to control cells. In contrast, 
depletion of mtDNA increased the promoter activity of CTRP5 
gene (unpublished results), which is known to increase its ex-
pression in mtDNA-depleted cells (10) and share structural and 
functional properties with CTRP6. This finding indicates that 
depletion of mtDNA up-regulated CTRP5 and CTRP6 expres-
sion via different mechanisms. Previous studies have reported 
that mitochondrial dysfunction can modulate gene expression 
via an increase in mRNA stability (20, 21). In this study, we found 
that up-regulation of CTRP6 gene in mtDNA-depleted cells was 
due to an increase in mRNA stability. Our recent study showed 
that the induction of micro RNA by mitochondrial dysfunction 
regulates IRS-1 expression at the translational level (22). Thus,  
it is possible that translational regulation is also involved in the 
up-regulation of CTRP6 in mtDNA-depleted cells. Further stud-
ies are needed to elucidate whether or not CTRP6 expression is 
regulated at the translational level under mtDNA-depleted con-
ditions. 
  AMP-activated protein kinase (AMPK) plays an important role 
in maintaining energy balance in the cells and contributes to 
protect the body from metabolic diseases such as type 2 diabe-
tes and obesity (23). High plasma fatty acid concentrations in-
terfere with insulin-stimulated glucose transport and are close-
ly associated with insulin-resistant states including obesity and 
type 2 diabetes (24). Adiponectin improves insulin sensitivity 
on skeletal muscle by activating AMPK (25, 26). Recently, we 
demonstrated that CTRP6 is involved in fatty acid metabolism 
in muscle cells via activation of AMP-activated protein kinase 
(AMPK), similar to adiponectin function (2). This finding sug-
gests the therapeutic potential of CTRP6 as a metabolic regula-
tor in metabolic diseases such as diabetes and obesity. Although 
both adiponectin and CTRP6 stimulate fatty acid oxidation via 
AMPK activation, the serum level of CTRP6 is significantly in-
creased in adiponectin-null mice (1). In agreement with this find-
ing, CTRP6 expression in adipose tissue is increased in 12-week-
old ob/ob mice, which express lower levels of adiponectin than 
control mice (1). It was reported that deletion of mtDNA induc-
es the AMPK energy stress pathway (27). Oxidation of both pal-
mitic and lignoceric acids is significantly increased in the liver 
of ob/ob mice with low mitochondrial respiratory chain activity 
(9). However, impartment of mitochondrial function decreases 
adiponectin synthesis (28). In this study, we observed that CTRP6 
expression was increased by depletion of mtDNA. Thus, it is pos-
sible that CTRP6 plays a role in compensating for the decrease 
in adiponectin expression under mitochondrial dysfunction. 
  In summary, the results in the present study show that deple-
tion of mtDNA increases CTRP6 gene expression in C2C12 cells. 
Furthermore, it is demonstrated that increased CTRP6 expres-
sion in mtDNA-depleted cells can be attributed to an increase 
in mRNA stability. Considering that CTRP6 is involved in fatty 
acid metabolism, our identification helps elucidate the molec-
ular mechanism for the control of energy homeostasis in mtD-
NA-depleted cells.
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